ALZAS, as a specific Aβ protein, may compete or even out-compete APP for the APP transmembrane transit site in specific neurons, paralleled by intraneuronal neurotoxic accumulation of Aβ[250] and activating phospholipases, resulting in an ongoing membrane decay and synaptic disruption in AD (Fig. 4) [256]. This evidence concerns the gene APP and Alzheimer disease.